Precision Oncology offers our sponsors invaluable clinical trial experience in a wide range of oncology indications, both hematologic and solid tumor types. Since 2000, we have managed over 325+ projects, spanning all phases of oncology drug development.
• Numerous, complex Phase I-II/proof-of-concept studies Global registrational programs
• Complex rescue studies, transitioned from other large and niche oncology contract research organizations
• Over 30 multiple myeloma studies
• Immuno-oncology studies
• Committed clinical research associates (CRAs) who can be dedicated exclusively to a single trial, averaging >12 years of monitoring experience